Kara Glazer1, Kelly Rootes-Murdy1, Michael Van Wert1, Francis Mondimore1, Peter Zandi2. 1. Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA. 2. Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA. Electronic address: pzandi1@jhu.edu.
Abstract
BACKGROUND: Measurement-based care (MBC) has emerged as an effective strategy for improving outcomes in patients with mood disorders. Suicide is a particularly devastating outcome of mood disorders. Using data from a new MBC program from the National Network of Depression Centers (NNDC), we examined whether capturing a patient-rated symptom measure, the patient health questionnaire (PHQ-9), along with a provider-rated global functioning measure, the clinical global impression scale (CGI-S), improves identification of patients at risk of suicide over using either measure alone. METHODS: A total of 126 adults with mood disorders from nine sites in the NNDC completed the PHQ-9 and CGI-S and had at least one subsequent visit where they completed the Columbia-suicide severity rating scale (C-SSRS). The PHQ-9 (≥10) and CGI-S (≥4) were dichotomized at commonly accepted severity thresholds. Associations of the PHQ-9 and CGI-S with suicidal ideation or behavior were examined using Firth's logistic regression to accommodate small samples while controlling for age, sex, race, and diagnosis. RESULTS: Patients who scored higher on only the PHQ-9 or CGI-S were not significantly more likely to experience subsequent suicidal ideation or behaviors. However, patients who scored higher on both the PHQ-9 and CGI-S were significantly more likely to experience suicidal ideation (OR = 4.70, p = 0.0005) and suicidal behaviors (OR = 25.38, p = 0.0003). DISCUSSION: Information from both patient and clinician-rated measures was better able to identify patients with mood disorders at risk for suicidal ideation and behaviors. Using both together may help reduce the risk of suicide by identifying those patients at greatest risk and allowing for more targeted interventions.
BACKGROUND: Measurement-based care (MBC) has emerged as an effective strategy for improving outcomes in patients with mood disorders. Suicide is a particularly devastating outcome of mood disorders. Using data from a new MBC program from the National Network of Depression Centers (NNDC), we examined whether capturing a patient-rated symptom measure, the patient health questionnaire (PHQ-9), along with a provider-rated global functioning measure, the clinical global impression scale (CGI-S), improves identification of patients at risk of suicide over using either measure alone. METHODS: A total of 126 adults with mood disorders from nine sites in the NNDC completed the PHQ-9 and CGI-S and had at least one subsequent visit where they completed the Columbia-suicide severity rating scale (C-SSRS). The PHQ-9 (≥10) and CGI-S (≥4) were dichotomized at commonly accepted severity thresholds. Associations of the PHQ-9 and CGI-S with suicidal ideation or behavior were examined using Firth's logistic regression to accommodate small samples while controlling for age, sex, race, and diagnosis. RESULTS:Patients who scored higher on only the PHQ-9 or CGI-S were not significantly more likely to experience subsequent suicidal ideation or behaviors. However, patients who scored higher on both the PHQ-9 and CGI-S were significantly more likely to experience suicidal ideation (OR = 4.70, p = 0.0005) and suicidal behaviors (OR = 25.38, p = 0.0003). DISCUSSION: Information from both patient and clinician-rated measures was better able to identify patients with mood disorders at risk for suicidal ideation and behaviors. Using both together may help reduce the risk of suicide by identifying those patients at greatest risk and allowing for more targeted interventions.
Authors: Suzanne E Gerritsen; Athanasios Maras; Larissa S van Bodegom; Mathilde M Overbeek; Frank C Verhulst; Dieter Wolke; Rebecca Appleton; Angelo Bertani; Maria G Cataldo; Patrizia Conti; David Da Fonseca; Nikolina Davidović; Katarina Dodig-Ćurković; Cecilia Ferrari; Federico Fiori; Tomislav Franić; Charlotte Gatherer; Giovanni De Girolamo; Natalie Heaney; Gaëlle Hendrickx; Alfred Kolozsvari; Flavia Micol Levi; Kate Lievesley; Jason Madan; Ottaviano Martinelli; Mathilde Mastroianni; Virginie Maurice; Fiona McNicholas; Lesley O'Hara; Moli Paul; Diane Purper-Ouakil; Veronique de Roeck; Frédérick Russet; Melanie C Saam; Ilyas Sagar-Ouriaghli; Paramala J Santosh; Anne Sartor; Aurélie Schandrin; Ulrike M E Schulze; Giulia Signorini; Swaran P Singh; Jatinder Singh; Cathy Street; Priya Tah; Elena Tanase; Sabine Tremmery; Amanda Tuffrey; Helena Tuomainen; Therese A M J van Amelsvoort; Anna Wilson; Leanne Walker; Gwen C Dieleman Journal: BMJ Open Date: 2021-12-16 Impact factor: 2.692
Authors: S E Gerritsen; L S van Bodegom; G C Dieleman; M M Overbeek; F C Verhulst; D Wolke; D Rizopoulos; R Appleton; T A M J van Amelsvoort; C Bodier Rethore; F Bonnet-Brilhault; I Charvin; D Da Fonseca; N Davidović; K Dodig-Ćurković; A Ferrari; F Fiori; T Franić; C Gatherer; G de Girolamo; N Heaney; G Hendrickx; R Jardri; A Kolozsvari; H Lida-Pulik; K Lievesley; J Madan; M Mastroianni; V Maurice; F McNicholas; R Nacinovich; A Parenti; M Paul; D Purper-Ouakil; L Rivolta; V de Roeck; F Russet; M C Saam; I Sagar-Ouriaghli; P J Santosh; A Sartor; U M E Schulze; P Scocco; G Signorini; S P Singh; J Singh; M Speranza; P Stagi; P Stagni; C Street; P Tah; E Tanase; S Tremmery; A Tuffrey; H Tuomainen; L Walker; A Wilson; A Maras Journal: Soc Psychiatry Psychiatr Epidemiol Date: 2022-02-10 Impact factor: 4.519
Authors: Roland M Jones; Kiran Patel; Mario Moscovici; Robert McMaster; Graham Glancy; Alexander I F Simpson Journal: Front Psychiatry Date: 2019-09-18 Impact factor: 4.157
Authors: Yiming Liang; Kankan Wu; Yongjie Zhou; Xin Huang; Yueyue Zhou; Zhengkui Liu Journal: Int J Environ Res Public Health Date: 2020-09-09 Impact factor: 3.390